Abbrea Capital’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,800
| Closed | -$251K | – | 175 |
|
|
2018
Q3 | $251K | Buy |
2,800
+215
| +8% | +$19.3K | 0.07% | 163 |
|
|
2018
Q2 | $205K | Sell |
2,585
-1,557
| -38% | -$123K | 0.06% | 166 |
|
|
2018
Q1 | $370K | Buy |
4,142
+125
| +3% | +$11.2K | 0.12% | 128 |
|
|
2017
Q4 | $419K | Sell |
4,017
-1,872
| -32% | -$195K | 0.14% | 116 |
|
|
2017
Q3 | $859K | Buy |
5,889
+595
| +11% | +$86.8K | 0.32% | 79 |
|
|
2017
Q2 | $688K | Buy |
5,294
+85
| +2% | +$11K | 0.27% | 84 |
|
|
2017
Q1 | $648K | Sell |
5,209
-100
| -2% | -$12.4K | 0.26% | 86 |
|
|
2016
Q4 | $615K | Buy |
+5,309
| New | +$615K | 0.29% | 84 |
|